Vantage Financial Partners (Wisconsin)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Vantage Financial Partners (Wisconsin)'s ABBV Position: Q4 2025 in Review
Vantage Financial Partners (Wisconsin) increased its AbbVie (ABBV) stake by 0.29% in Q4 2025, buying an estimated $7.29K and bringing the position to 11,120 shares worth $2.54M. The position accounts for 0.52% of the portfolio, ranked #31.
Vantage Financial Partners (Wisconsin) first reported a position in ABBV in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.57M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.
- Vantage Financial Partners (Wisconsin) held 11,120 shares of AbbVie worth $2.54M as of Q4 2025.
- Vantage Financial Partners (Wisconsin) bought 32 AbbVie shares in Q4 2025, an estimated $7.29K.
- AbbVie made up 0.52% of Vantage Financial Partners (Wisconsin)'s portfolio in Q4 2025, its #31 holding.
- Vantage Financial Partners (Wisconsin) first reported a position in AbbVie in Q3 2024 and has held it in 6 quarters since.
- Vantage Financial Partners (Wisconsin)'s AbbVie position peaked at $2.57M in Q3 2025.
- 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.
Based on Vantage Financial Partners (Wisconsin)'s 13F filing for Q4 2025, filed 3 Feb 2026.